Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
04. Dezember 2024 12:00 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
26. November 2024 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
14. November 2024 16:30 ET
|
Milestone Scientific, Inc.
Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following...
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
14. November 2024 16:00 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
12. November 2024 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care
01. November 2024 09:15 ET
|
Milestone Scientific, Inc.
Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE...
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment
03. Oktober 2024 11:00 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
15. August 2024 07:00 ET
|
Milestone Scientific, Inc.
Secured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year...
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
12. August 2024 11:00 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
07. August 2024 10:00 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...